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Background: A repeat breeder cow (RBC) can be defined as an animal that after 3 or more inseminations cannot
get pregnant because of fertilization failure or early embryonic death. If no cause is identified precisely, inadequate
uterine receptivity is responsible for implantation failures. Since a large number of identified molecular mediators,
such as cytokines, growth factors and lipids have been postulated to be involved in early feto-maternal interaction,
in this study a different approach to the treatment of RBC syndrome has been employed using a platelet concentrate
(PC) that contains a significant amount of growth factors accumulated in its α-granules.
Methods: Three explorative studies were performed. Initially, PC was supplemented in the in vitro embryo culture
medium to study its effect on embryo-development. After the pilot study, 4 RBCs were treated with intrauterine
administration of PC to evaluate proliferative potential of endometrium by immunohistochemical expression of
the antigen Ki-67. Lastly, the effect of intrauterine administration of PC at 48 hrs after artificial insemination in RBCs
was evaluated.
Results: The in vitro results show that 5 % of PC and 5 % of fetal calf serum (FCS) increase the rate of blastocysts
compared with the control containing 10 % FCS only (43.04 % vs 35.00 % respectively). The immunohistochemical
study shows more proliferating nuclei in the treated uterine horn compared to the control one. After intrauterine
insemination in RBCs, the percentage of pregnant cows in the control group was 33.33 % compared to 70 % of the
treated animals.
Conclusion: We suppose that when embryo descends in uterus could find a more appropriate environment for
nesting and subsequent pregnancy.
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Unexplained infertility, the so called repeat breeder cow
(RBC) syndrome, involves a heterogeneous group of
sub-fertile cows, with no anatomical abnormalities and
infections of the reproductive tracts, nor estrous cycle
alterations. A repeat breeder is defined as a cow that
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unless otherwise stated.as a consequence of either fertilization failure or early
embryonic death [1].
The etiology of RBC syndrome is multi-factorial and un-
clear. The normal uterine environment promotes normal
embryonic development but subclinical disorders com-
promise the survival of the embryo resulting in RBC
syndrome. The RBCs are characterized by early embry-
onic loss [2], that decreases the conception rates [3, 4].
In some cases, the transfer of non-RBC donated em-
bryos into RBC surrogates increased RBC pregnancy
rate, indicating that the lower conception rate of RBCs
is determined at early stages of embryo development
[3]. The problem could be the embryo but also theAccess article distributed under the terms of the Creative Commons
.org/licenses/by/4.0), which permits unrestricted use, distribution, and
riginal work is properly credited. The Creative Commons Public Domain
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[5] provided evidence that RBC syndrome is associated
with oocyte quality and that this negative effect is en-
hanced during summer heat stress, but it is general
opinion that the successful implantation requires also a
complex sequence of signaling events that are crucial
to the establishment of pregnancy. In human medicine
there is a proportion of women with ‘unexplained’
infertility in whom pregnancies fail before they are
clinically recognized. Koot et al. [6] underline that this
infertility could occur as a result of a malfunction of
the endometrial-embryo ‘dialogue’ after the early phases of
implantation. Indeed, the uterus is responsible for two-
thirds of failures whilst the embryo for only one-third
[7, 8]. A large number of molecular mediators, under the
influence of ovarian hormones, have been postulated to be
involved in this early embryo-maternal interaction. These
mediators embrace a large number of inter-related mole-
cules including adhesion molecules, cytokines, growth fac-
tors, lipids and others [9, 10]. Many treatments have been
proposed for prevention of RBC syndrome at both herd
and individual level. These include, for example, nutri-
tional supplements and assisted reproductive techniques,
such as in vitro embryo production and embryo transfer.
Commonly, therapies in use include hormonal treatments
with progestins, GnRH, exogenous gonadotrophins and
prostaglandins [1]. However, in view of the embryo-
maternal interaction a different approach to the treatment
of RBC syndrome could be found using platelet concen-
trate (PC). Platelets contain significant quantities of
growth factors (accumulated in their α-granules), chemo-
kines and cytokines and also active metabolites [11], that
act in a paracrine manner on different cell types like myo-
cytes [12], mesenchymal stem cells of different sources
[13], condrocytes [14, 15], osteoblasts [16], fibroblasts
[17]. Moreover, several in vitro studies have shown a direct
dose–response influence of many growth factors on cell
migration, cell proliferation, and matrix synthesis [18–20].
Transforming growth factor β1 (TGF-β1) and TGF-β2,
platelet derived growth factors (PDGF-AA, PDGF-BB,
PDGF-AB), insulin-like growth factor 1 (IGF-I), epidermal
growth factor (EGF), vascular endothelial growth factor
(VEGF), fibroblast growth factor (FGF) and hepatocyte
growth factor (HGF) are very important for regeneration
processes. Indeed, these growth factors act synergistically
to increase the infiltration of neutrophils and macro-
phages, to promote angiogenesis, fibroplasia, matrix de-
position and, ultimately, re-epithelialization, inducing
the consequent tissue regeneration [21]. Lastly, it is known
the anti-inflammatory property of PC by the presence of
anti-inflammatory agents including HGF [22].
In this context, the uterine administration of PC may
be useful in peri-implantation, or in the healing process
of clinically silent endometrial injuries because manycytokines act as intermediary links in the materno-fetal
relationship including decidualization (in the women),
implantation, placentation, embryogenesis and fetal
growth [23]. Moreover, since pro-inflammatory factor
transcripts in bovine endometrial epithelial cells are ele-
vated in case of subclinical or clinical endometritis [24],
we hypothesized that an early administration of PC, after
artificial insemination (AI) and before the descent of the
blastocyst in the uterus, could improve the uterine
microenvironment for embryo implantation and coun-
teract eventual subclinical endometritis.
Methods
Materials
Chemicals were obtained from Sigma Chemical (Milan,
Italy) and tissue culture plastic dishes from Euroclone
(Milan, Italy) unless otherwise specified.
Experimental Design
This study was based on three experiments as summarized
in Table 1. The first experiment was to evaluate the effect
of PC on in vitro embryo production by replacing fetal calf
serum (FCS) with PC to establish whether this product is
able to support embryo development. The second experi-
ment evaluated the endometrium immunohistochemically,
after in vivo PC administration, using Ki-67 as a marker of
cell proliferation. The third in vivo experiment evaluated
embryo implantation and development in RBCs following
intrauterine administration of PC at 48 h after artificial
insemination (AI).
Animals and repeat breeder syndrome diagnosis
All procedures were performed according to approved
animal care and use protocols of the institutional ethics
committee and to good veterinary practice for animal
welfare as to European directive 2010/63/UE. Moreover,
written farmers’ consent was obtained at the beginning
of the study.
The study was performed between January and April to
reduce the influence of climate (i.e. a hot and humid cli-
mate, heavy rain, heat stress). Indeed, in the Italian envir-
onment late winter is probably the most stable period,
with a low rain rate and temperature between 0 and 10 °C.
A total of 64 animals Holstein Friesians in which preg-
nancy had not been achieved despite 3 or more insemina-
tions were enrolled in this study. Ultrasound examination
was performed in each cow to detect any reproductive
pathology (like ovarian cysts, pyometra, abscess…) that
would result in exclusion of cows from the experiment be-
cause not considered RBCs. For each cow, on the day of
the estrus, cervical mucus was tested and samples of cer-
vical mucus were collected aseptically by swab (Equi-Vet,
Kruuse, Marslev, Denmark). Bacteriological examinations
were performed as reported by Gani et al. [25].
Table 1 Experimental design
Experiments N° samples Parameter evaluated
1 In vitro: effect of different amounts of PC on embryo development 705 oocytes • Rate of embryos
• Total cell numbers per blastocyst
2 In vivo: evaluation of endometrial cell proliferation, after in vivo PC
administration
4 RBCs Microscopic nuclear count of cells
expressing Ki-67
3 In vivo: embryo implantation and development after intrauterine
administration of PC
30 Treated RBCs 30 Control
RBCs
Rate of pregnancy
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weekly milk production of 128.6 ± 0.7 kg, 6.05 ± 4.84
previous inseminations (minimum of 3 and maximum
of 23 inseminations per animal), and were on lactation
number 2.7 ± 0.2.
Preparation of Platelet Concentrate (PC)
Blood was obtained from 8 donor cows, at the forty days
in milking because in this period the circulating platelet
counts is higher than other periods (data not shown),
in good health, free from infection that had not re-
ceived medication during the previous two months.
The collection of blood and the preparation of PC, with
the method of double centrifugation, were performed
as reported by Lange-Consiglio et al. [26]. Briefly, after
surgical scrub preparation of a few centimetres of skin
around the subcutaneous mammary vein, 450 ml of
blood was collected in ad hoc Terumo blood bags (Terumo
Srl, Rome, Italy) containing CPDA-1 by using the 16 gauge
needle provided with the bags. The bags were transported
at +4 °C to the laboratory within 2 hrs of collection and
immediately processed. All separation steps to produce PC
were performed under a horizontal laminar flow hood in
aseptic conditions. To prepare the PC, the blood was
drawn into sterile Falcon tubes of 50 ml each. The tubes
were centrifuged at 100xg for 30 min. This caused separ-
ation of the blood into three components: red blood cells
at the lowest level, ‘buffy coat’ comprised in the middle
layer, and platelet-rich plasma (PRP) in the upper layer.
Afterward, the PRP was carefully aspirated and distributed
in new 50 ml tubes and centrifuged again at 1500xg for
10 min to obtain the platelet pellet and the poor platelet
plasma (PPP) at the upper layer. Afterwards, two thirds of
the volume of PPP was aspirated for later use and the pel-
let mixed in the residual PPP volume to allow for platelet
count before the final dilution with PPP to obtain PC at a
standard concentration of 1x109 platelet/ml. All platelet
counts on peripheral blood, PRP and PC were performed
by an automatic hematology analyser HeCo Vet SEAC
(Florence, Italy).
At the end of the process, PC was pooled and pre-
pared at a standard concentration of 1 × 109 platelet/ml.
The total volume of PC was aliquoted into 10 ml usage
doses that were stored in syringes. To release plateletderived factors, three cycles of freezing at −80 °C and
thawing at 37 °C were performed [27]. Syringes containing
PC dose were kept frozen at −20 °C until use. The same
pool of PC obtained from donor cows was used in all
experiments and in all animals in an heterologous way
meaning that it was employed in cows different from
donor cows.
For supplementation in in vitro cultured embryos, to
prevent coagulation and clot formation, a fibrinogen free
PC was prepared as reported by Mojica-Henshaw et al.
[28]. Briefly, after thawing, pooled PC was centrifuged at
4000 g for 20 min, and the supernatant was collected
and was manufactured by adding calcium chloride
(20 % w/v) at a ratio of 1:100. After allowing the product
to form a clot overnight at 4 °C, the coagulated product
was centrifuged at 4000 g for 20 min, and the super-
natant was collected to obtain fibrinogen free PC.
Experiment 1: effect of PC on in vitro embryo production
The in vitro embryo production consisted of 3 steps:
in vitro maturation of oocytes (IVM), in vitro fertilization
(IVF) and in vitro culture of embryo (IVC) performed on a
monolayer of cumulus cells. These steps were carried out
as reported by Lange-Consiglio et al. [29]. Briefly, cumu-
lus–oocyte complexes (COCs) were collected from ovaries
obtained from an abattoir by aspirating follicles 2–8 mm
in diameter and washing them twice in preincubated
(38.5 °C, 5 % CO2 in air) TCM 199-HEPES buffered
culture medium supplemented with 10 % FCS.
IVM was performed for 24 h in TCM 199 Earl’s Salt
medium supplemented with 10 % FCS, 5 μg/ml LH
(Lutropin, Bioniche, Canada), 0.5 μg/ml FSH (Folltropin,
Bioniche, Canada), 0.2 mM sodium pyruvate, 10 μg/ml
gentamycin and 1 mg/ml estradiol 17β. Cultures were in
70 μl droplets (up to 20 oocytes/droplet) of the medium
under oil, at 38.5 °C in 5 % CO2.
IVF was performed in Tyrode’s-albumin-lactate-pyru-
vate (TALP) medium containing 2 mM penicillamine,
1 mM hypotaurine, 250 mM epinephrine and 20 μg/ml
heparin. Frozen–thawed semen was prepared by Percoll
gradient (Amersham Pharmacia Biotec, Upsala, Sweden).
In a 15 ml conic tube, 1 ml Percoll 90 % was added
followed by 1 ml Percoll 45 %. Semen was thawed at
37 ° C for 30 sec, placed on the top of the Percoll
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moval of the supernatant, 4 ml TALP medium were
added and the sample centrifuged again for 2 min at 200
xg to remove excess Percoll.
Semen (107 spermatozoa/ml) was co-incubated with
matured oocytes for 18 h at 38.5 °C in 5 % CO2. At the
end of gametes co-culture, the cumulus cells were com-
pletely removed and evaluation of segmentation was
carried out from the first day of embryo culture (con-
sidering as day zero the day of insemination) when em-
bryos were equally divided into three different embryo
culture media: 1) standard embryo culture medium
(TCM-199) with 10 % of FCS; 2) standard medium sup-
plemented with 5 % FCS and 5 % PC; 3) standard
medium supplemented with 10 % PC. The percentage
of embryos developing to blastocyst stage was evaluated
daily up to day 7 after fertilization. Some blastocysts, as
reported in Table 2, were stained with Hoechst 33342
(10 μg/ml) for 10 min, and total cell numbers were
counted under an epifluorescence microscope to esti-
mate embryo quality. Hoechst 33342 dye was excited at
353–365 nm while the emission wavelength was set at
460 nm.Experiment 2: immunohistochemical analysis of
endometrium after in vivo PC administration
Four RBCs, belonging to the group previously described,
culled by owner decision were used to test the effect of
PC on endometrial cell proliferation. On the ninth day
of diestrous stage, 10 ml of PC were administered into
uterine horn ipsy-lateral (two cows) or contra-lateral
(two cows) to the corpus luteum, maintaining the op-
posite horn as a control. After PC administration, a
Foley catheter was inserted in the control horn and the
balloon was inflated to prevent passage of PC and create
the control environment. Our previous study (data not
shown) demonstrated that insertion of a Foley catheter
for 3 days does not alter the normal histological appear-
ance of endometrium. These cows were slaughtered
3 days after the treatment (on the twelfth day of diestrus
stage) and the 4 uteri were evaluated macroscopically forTable 2 Number of blastocysts at 7 days in three different
culture media and total cell number per blastocysts
Medium N° of blastocysts







CTR (10 % FCS) 84/240 (35.00 ± 1.72)a 29 104.6 ± 10.5a
FCS 5 % + PC 5 % 99/230 (43.04 ± 1.42)b 31 123.4 ± 8.3b
PC 10 % 64/235 (27.23 ± 1.39)c 34 98.7 ± 6.4c
The number are expressed as mean ± standard deviation (SD)
Different small letters superscript (a, b) in the same column indicate statistically
different comparisons (P < 0.05)differences between the treated and the control horns.
For each horn, samples of middle/cranial portion were
collected in formalin solution and were examined immu-
nohistochemically for expression of the nuclear antigen
Ki-67, a marker of cell proliferation, using the ABC-
peroxidase method as reported by Turner et al. [30].
Briefly, the tissue was fixed in 4 % buffered formalin,
dehydrated, and embedded in paraffin. Sections 4 μm
thick were mounted on aptes (3-aminopropyl triethoxy
silane, Sigma) coated slides, dewaxed, and rehydrated.
Sections were immunostained using the standard ABC
technique with the rabbit antihuman/horse polyclonal
antibody to Ki-67 (Dako Italia, S.p.A., Milan. Italy) used
at 1:50 dilution. Ki-67 antibody is directed against differ-
ent epitopes of the proliferation-related antigen and can
be used on fixed sections. Endogenous peroxidase activ-
ity was blocked using 3 % hydrogen peroxide. Pre-
treatment with microwaving in sodium citrate buffer,
pH 6, was used. Non-specific primary antibody binding
was blocked using fetal calf serum at a dilution of 1:20
for the ABC Ki-67. The primary antibody was applied
for 18 hrs at +4 °C and washed in buffered saline. An
antirabbit biotinylated secondary antibody (Insight Bio-
technology Limited, Wembley Middlesex, UK) was ap-
plied at 1:200 dilution for 30 min at room temperature,
followed by washes and then by application of the horse-
radish peroxidase streptavidin complex (Dako) at 1:400
dilution for 30 min. The anti-rabbit secondary antibody
is an affinity-purified polyclonal antibody with well-
characterized specificity for rabbit IgG. Colour develop-
ment was with metal enhanced diaminobenzidine (DAB)
(Pierce and Warriner Ltd, Chester, UK) applied for
15 min. The slides were lightly counterstained with
Mayer emallume. The sections were viewed under a
photomicroscope Olympus BX51 and nuclear count was
performed on each section, at the level of endometrial
epithelial cells, as number of positive cells to detect the
entity of cell proliferation. Three different sections per
cow and 4 microscopy fields for each section were
counted.Experiment 3: in vivo effectiveness of intrauterine
administration of PC at 48 h after AI in RBCs
This experiment was carried out in 2 farms, managed in
a cubicle yard. Sixty RBCs were randomly allocated into
two groups: “treated group” (N = 30) that received intra-
uterine administration of PC 48 hrs after AI and “control
group” (N = 30), that received no treatment in addition
to AI. Treated group were characterized by 6.0 ± 5.19 in-
seminations prior to the enrollment in the study while
control cows showed 6.1 ± 4.49 inseminations.
Cows displaying estrus in either group were submitted
for insemination. The semen from the same bull was
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“bull” effect in the results of fertility.
All the cows were blood sampled for progesterone
assay at day 0 (day of insemination), and then 4 and
8 days after insemination (respectively T0, T4 and T8).
At 48 hrs after insemination, 10 ml of PC at 1 x 109
platelet/ml were administered into the uterus in the
cows in the treated group. This time was supposed to
be ideal after AI not to disturb spermatozoa progres-
sion and before the embryo reaches the uterus. Ten ml
of PC were administrated following previous study
(data not shown) in which this volume proved to be
evenly distributed along the uterine horns without
signs of excessive distension allowing to reach the dee-
pest portion of the organ. Ultrasound examination for
pregnancy diagnosis was performed in all cows 32 days
after insemination and confirmed at 60 days.
Bacteriological examination of cervical mucus
Bacteriological investigations were performed to detect
aerobic and anaerobic microorganisms, such as True-
perella pyogenes, Haemophylus sommni, Staphylococcus
sp., Streptococcus sp., Enterobacteriaceae, Prevotella sp.,
Fusobacterium spp. Each sample was plated on blood
agar (agar with 5 % sheep blood, Sintak, Italy) for iso-
lated colonies. The plates were incubated for 24–48 hrs
in aerobic and anaerobic conditions at 37° ± 2 °C. Iden-
tification of bacteria was based on colonial morphology,
Gram staining, and biochemical tests such as catalase,
oxidase, coagulase according to the guidelines of the
Bergey’s manual of Systematic Bacteriology and the
standard bacterial procedure of CLSI (Clinical and
Laboratory Standards Institute) and confirmed by
API-System (bioMerieux, France).
Intrauterine administration of platelet concentrate
After thawing and warming at 38 °C, the syringes of
PC were connected to a sterile disposable intrauterine
cannula, so that samples could be delivered through
the vestibule, the vagina and the cervix to reach deep
into the uterine horn ipsi-lateral to the newly formed
corpus luteum. Plastic catheters with atraumatic ends
were used. Ten ml of PC were administrated to cows
in the treatment group 48 hrs after insemination.
Progesterone assay
Plasma samples were obtained by jugular venipuncture
(2-5 ml). Blood was collected in heparinized tubes and
centrifuged at 1000xg for 10 min. The plasma concen-
tration of progesterone was assessed using a quantitative
automated method based on the enzyme-linked fluores-
cent assay (ELFA) technique (Mini-Vidas; bioMérieux
Italia S.p.A., Florence, Italy.Statistical analysis
The collection efficiency of platelets for each PC was
analyzed using the following formulas [31]:
efficiency for platelet collection
¼ platelet count=μl in PC x volume of PC
platelet count in whole
blood=μl x volume of whole blood
The statistical analysis of the data collected during the
study, except for bacteriological data, was conducted
using chi-square test. For all tests, differences were con-
sidered statistically significant when P ≤ 0.05. The data
were analyzed using the “Software GraphPad Instat 3.00
for Windows” (La Jolla, CA, USA).Results
Platelet collection efficiency and product sterility test
The platelet collection efficiency for the PCs was 10.9 ±
2.3 %, indicating that 10.9 ± 2.3 ml of PC at the concentra-
tion of 1x109 platelet/ml were obtained from 100 ml of
blood.
The bacterial sterility test performed on the PC pro-
duced in the laboratory has always given negative results,
confirming that the experimentation has been performed
in accordance with the appropriate standards of laboratory
sterility.Experiment 1: effect of PC on in vitro embryo production
During three experiments, 168 ovaries were processed,
705 oocytes were collected, with an average of 4.2 oo-
cytes collected per ovary. The results related to the
culture of embryos in the standard medium (CTR)
show that the rate of cleavage of three replicates is
66.80 ± 2.07.
Results related to embryo culture show that the rate of
blastocyst development was statistically significant differ-
ent (P < 0.001) among all the three media tested and the
best embryo production rate and quality was achieved in
the culture medium supplemented with 5 % PC and 5 %
FCS (Table 2).Experiment 2: immunohistochemical analysis of
endometrium after in vivo PC administration
No macroscopic alterations were observed in any of the
uterine samples. Immunohistochemical examination for
the unmasking of the nuclear antigen Ki-67 showed that
in all animals there were statistically more proliferating
nuclei in the treated uterine horn compared to the con-
trol one (Table 3 and Fig. 1).
Table 3 Microscopic nuclear count of cells expressing nuclear antigen Ki-67 protein in control (CTR) and treated (TRT) uterine horns
of 4 cows in different sections and different microscopic fields
1 2 3 4
Uterine horn Uterine horn Uterine horn Uterine horn
CTR TRT CTR TRT CTR TRT CTR TRT
2 ± 0.7a 12 ± 0.2b 1 ± 0.2a 10 ± 0.6b 5 ± 2.9a 18 ± 2.3b 14 ± 3.8a 40 ± 4.2b
Legend: CTR Control; TRT Treated. The number are expressed as mean ± standard deviation (SD)
Different small letters superscript (a, b) in the same line indicate statistically different comparisons (P < 0.05)
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administration of PC at 48 hrs after AI in RBCs
The clinical aspect of the uterus in all animals during the
clinical examination at the estrous stage appeared normal
in size, without presence of drains and with adequate,
clear and stringy estrous mucus.
Progesterone values did not differ from those expected
in a normal estrous cycle. Indeed, these values were
lower than 1 ng/ml during peri-estrus and then in-
creased gradually at day +4 as a result of ovulation and
further increased at day +8 post insemination (Table 4).
The percentage of pregnant cows in the control group
was of 33.33 % (10/30) compared to 70 % (21/30) of the
treated animals. The difference in pregnancy rates be-
tween the treated group and the control group was sta-
tistically significant (P < 0.05; Table 4). There was no
correlation between treatment results and number of
past inseminations before this study and characterizing
the status of the enrolled RBCs (P = 0.62). All treated
and control RBCs diagnosed as pregnant gave birth to
normal offsprings.Microbiological results
No significant bacterial growth was observed in any of
the cervical mucus samples obtained from cows of both
experimental groups. The microorganism Aerococcus
viridans was isolate only from one cow.Fig. 1 Immunohystochemical analysis. Nuclear positivity to Ki-67
protein. Magnification 100xDiscussion
Studies in humans and in other mammals have shown
that cytokines and growth factors are produced by the
pre-implantation embryo and cells of the reproductive
tract, even if the exact combinations required for suc-
cessful implantation are not yet fully understood [23].
Based on the current knowledge of the regenerative ef-
fect of PC due to its high growth factor and cytokine
content [22], this study proposes a novel therapeutic ap-
proach. Autologous PC is known to accelerate the heal-
ing process in human medicine, and has been used in
maxillofacial surgery, muscle and/or tendon repair, and
reversal of skin ulcers [21]. In veterinary medicine there
are few clinical reports of the use of PC. It has been
mainly used for promoting equine tendon repair [32],
but there are some reports of its use in intestinal wound
healing in pigs [33], in a large cutaneous lesion in a dog
[34] and in bovine mastitis in which it was used in heter-
ologous way [26]. In all cases PC or platelet rich plasma
showed a clear regenerative potential.
For this reason, in this preliminary investigation, we per-
formed three explorative studies in vitro and in vivo. Only
one paper [35] described the effects of platelet rich plasma
on morula and blastocysts in vitro production. In our
study and in our experimental conditions (i.e. platelet con-
centration at 1x 109/ml), at first we studied the effect of
PC on in vitro embryo development using two different
percentages (respectively 5 % and 10 %) of PC as a partial
or complete replacement of FCS. The rate of blastocyst
production and the total cells number of the blastocysts
were statistically increased in the medium with 5 % PC
and 5 % FCS when compared to both the control and
medium with 10 % PC. Platelets release many growth fac-
tors, including FGF, TGF-6, PDGF and EGF [36, 37] that
can stimulate bovine embryo development [38, 39]. In-
deed, Munson et al. [40] demonstrated that TGF-6 and
PDGF act synergistically to promote proliferation of both
bovine trophoblastic cells and endometrial epithelial cells
during in vitro culture. Moreover, EGF in vivo is produced
by endometrial cells and its receptors have been detected
in the embryo itself, where EGF acts through the phos-
phorylation of membrane proteins as a mitogen, promot-
ing DNA and RNA synthesis. As pregnancy progresses,
the increased production of EGF enhances trophoblast dif-
ferentiation [41], promoting cell attachment and embryo
Table 4 Results of in vivo effectiveness of intrauterine administration of PC 48 h after AI in RBCs
Progesterone value (ng/ml)
N°cows T0 T4 T8 Pregnant (%) Not Pregnant (%) Delivery (%)
Control 30 0.40 ± 0.21a 2.63 ± 0.96a 7.75 ± 2.21a 10 (33.33)a 20 (66.67)a 10 (100)
Treated 30 0.40 ± 0.17a 3.12 ± 0.85a 8.33 ± 2.14a 21 (70.00)b 9 (30.00)b 21 (100)
Different small letters superscript (a, b) in the same column indicate statistically different comparisons (P < 0.05)
Lange-Consiglio et al. Reproductive Biology and Endocrinology  (2015) 13:65 Page 7 of 9development [23]. Fibronectin and other glycoproteins are
also released from platelets after aggregation, and Larson
et al. [42] discovered that a serum-free medium supple-
mented with fibronectin provides the extracellular matrix
required by the embryo to develop to the blastocyst stage
during in vitro culture. In a speculative interpretation, the
embryo culture systems supplemented with PC may have
provided TGF-6, PDGF and the matrix of extracellular fi-
bronectin necessary to support the development of em-
bryo during in vitro culture, thus replicating the uterine
microenvironment appropriate for embryo growth, viabil-
ity, and for cytokine secretion [23]. It is possible that the
low rate of embryos obtained in the medium with 10 %
PC, compared to control, results from an excess of factors
that may have had an inhibitory effect on the embryo
development.
This in vitro study provided a useful starting point for
the pre-clinical investigation in order to use PC in in vivo
trials. Immunohistochemical examination of uterine sam-
ples from animals slaughtered 3 days after PC treatment
showed that there was more expression of the nuclear anti-
gen Ki-67 in samples from treated uterine horns compared
to the controls. Cell proliferation is not enough indicative
for uterine health but Ki-67 is expressed in the nuclei of
proliferating cells. In tissues with a high proliferative rate it
is expressed in all cell cycle phases except for the resting or
G0 phases [43, 44] and reaches a maximum level during
G2 and M [45]. Since Ki-67 is significantly more expressed
in samples from treated uterine horns, it may be supposed
that the growth factors released by platelets in the PC may
have an effect on endometrial cell proliferation.
After these preliminary studies, the in vivo administra-
tion of PC into the uterus of RBCs at 48 hrs after insem-
ination was performed.
The gynecological clinical status and the progesterone
analysis performed in this study ensured that pregnancy
losses in enrolled animals were not caused by abnormal
ovarian cycles, an important condition for classification
of cows as RBC, as reported by Gustafsson et al. [46].
The progesterone analysis also allowed us to exclude
hypoluteinism as a possible cause of repeat breeding. In
fact, all animals showed progesterone values exceeding
the 2 ng/ml threshold both at day +4 and +8 post-
insemination [47]. Moreover, bacteriological examination
performed on cervical mucus confirmed the absence of
bacterial infections in the genital tract, as the onlyisolated microorganism was Aerococcus viridans, a bac-
terium not recognized as a uterine pathogen.
In the in vivo study, there were more pregnant cows in
the treated group compared to the control group. This
suggests that the in vivo intrauterine administration of PC
48 hrs after insemination, time supposed to be ideal after
AI not to disturb spermatozoa progression and before the
embryo reaches the uterus, could make the uterine envir-
onment favorable to embryo implantation. This may be
the effect of platelet growth factors on regeneration and/
or the healing of clinically silent endometrial abnormal-
ities. Furthermore, PC should enrich the uterine environ-
ment with factors necessary for embryo development.
Uterine glands produce a glycoprotein-rich secretion,
which is believed to support the embryo during the
pre-implantation period [48]. In addition to providing
nutrition for the conceptus, this secretion contains a
complex array of growth factors and cytokines. Katagiri
and Takahashi [49] reported that RBCs show abnormalities
in the growth factor-cytokine network - specifically in
endometrial EGF concentrations. Cyclic cows have two
peaks of EGF concentrations on days 2–4 and 13–14 of the
oestrous cycle, but these peaks are lost or diminished in
about 70 % of RBCs [49]. The EGF family could act on the
trophectoderm promoting cell attachment and embryo de-
velopment [23]. Since PC contains EGF, treatments target-
ing the endometrial growth factor regulatory network may
be an effective way to deal with RBCs when uterine prob-
lems limit the production of this or other growth factors.
Conclusions
The preliminary data regarding the administration of PC
into the uterus of animals at 48 hrs after insemination
produced very encouraging results in RBCs. From our
data, we hypothesize that PC, whose content is known,
enriches the uterine environment with factors necessary
for embryo development and counteracts eventual sub-
clinical endometritis by its anti-inflammatory properties.
The obtained results in our three different explorative
studies are very interesting. This research could offer a
new therapeutic strategy for RBC syndrome and also
open the possibility for using PC in future embryo-
transfer programs in both human and veterinary medi-
cine as a vehicle to transfer embryos at the time of
transplantation, with the aim of improving the uterine
environment for implantation.
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